About this article
Medically reviewed- Written by
- Dr Paul Watson
- Medically reviewed by
- Dr Han Simpson
- Published
- July 30, 2026
- Medical review date
- September 8, 2026
- Evidence searched through
- September 8, 2026
- Next review due
- September 8, 2027
- Intended audience
- General Readers & Patients
- Geographic scope
- Worldwide
- Conflicts of interest
- None declared.
- Funding
- Website Owner
- Report a correction
- Report an error or editorial concern
- Medical disclaimer
- Read the medical disclaimer
Precision medicine is transforming healthcare by shifting away from a one-size-fits-all approach to treatment. Instead, clinicians and researchers are increasingly using biological data to better understand disease, predict treatment response, and develop therapies tailored to individual patients. At the heart of this evolution is biomarker testing, which provides valuable insights into the molecular and cellular processes that influence health and disease.
As scientific knowledge continues to expand, biomarkers are playing an increasingly important role in diagnostics, drug development, and clinical decision-making. Their ability to support personalised care has made them a cornerstone of modern medical research.
What Are Biomarkers?
A biomarker is a measurable biological characteristic that can indicate normal physiological processes, disease activity, or a patient’s response to treatment. Biomarkers may include proteins, genes, metabolites, antibodies, or specific cellular characteristics that provide clinically relevant information.
Different types of biomarkers serve different purposes. Diagnostic biomarkers help identify the presence of disease, prognostic biomarkers provide information about likely disease progression, and predictive biomarkers can indicate whether a patient is likely to benefit from a particular therapy. Together, these tools allow clinicians to make more informed decisions throughout the patient journey.
Supporting Precision Medicine
The goal of precision medicine is to deliver the right treatment to the right patient at the right time. Biomarker testing makes this possible by helping healthcare professionals better understand the biological differences between patients, even when they share the same diagnosis.
For example, many cancers that appear similar under a microscope have distinct molecular profiles. Biomarker testing can identify these differences, enabling clinicians to select targeted therapies that are more likely to be effective while avoiding treatments that may offer limited benefit. This personalized approach has improved treatment strategies in oncology and is expanding into areas such as autoimmune diseases, infectious diseases, neurology, and cardiovascular medicine.
Accelerating Clinical Research
Biomarker testing has become an essential component of clinical research and drug development. Researchers use biomarkers throughout the development process to better understand disease mechanisms, identify suitable patient populations, monitor biological responses, and evaluate treatment effectiveness.
Incorporating biomarkers into clinical trials can improve study design by selecting participants who are most likely to respond to an investigational therapy. This approach may increase trial efficiency, reduce variability, and generate more meaningful clinical data.
As precision medicine continues to evolve, biomarker-driven clinical trials are becoming increasingly common, particularly in therapeutic areas where targeted treatments are under development.
High-Quality Laboratory Testing
Generating reliable biomarker data requires specialized laboratory expertise, validated analytical methods, and rigorous quality standards. From assay development through sample analysis and data interpretation, every stage of the testing process contributes to the accuracy and reproducibility of research findings.
Organizations involved in translational research and clinical development often rely on specialist laboratories that provide comprehensive biomarker solutions to support biomarker discovery, validation, and clinical trial programs. Access to advanced laboratory capabilities helps ensure that biomarker data can be generated consistently across studies while meeting regulatory and scientific requirements.
Challenges and Future Opportunities
Although biomarker testing has already transformed many areas of medicine, challenges remain. Standardizing assays across laboratories, validating new biomarkers, and integrating complex biological data into routine clinical practice continue to require collaboration between researchers, healthcare providers, regulators, and laboratory specialists.
Emerging technologies, including next-generation sequencing, artificial intelligence, digital pathology, and multi-omics analysis, are expected to further expand the role of biomarkers in precision medicine. These innovations have the potential to identify previously unknown disease signatures and support even more personalised approaches to diagnosis and treatment.
As research progresses, the number of clinically useful biomarkers is likely to continue growing, opening new opportunities to improve patient outcomes across a wide range of diseases.
Looking Ahead
Biomarker testing is helping to redefine modern healthcare by providing the biological insights needed to support precision medicine. From identifying disease earlier to guiding targeted therapies and improving clinical trial design, biomarkers are enabling more personalised and effective approaches to patient care.
As scientific understanding deepens and laboratory technologies continue to advance, biomarker testing will remain a critical driver of innovation in both clinical research and routine healthcare, helping researchers and clinicians deliver better outcomes for patients worldwide.